MMedication Read More Novo Nordisk beyond weight loss has investors wary, scientists hopefulJanuary 1, 2026 Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…
HHealthcare Read More Johnson & Johnson halts mid-stage trial of experimental eczema drugDecember 26, 2025 Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
HHealthcare Read More UnitedHealth Group releases results of independent auditDecember 19, 2025 UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans |…
HHealthcare Read More Obesity pills from Novo Nordisk, Eli Lilly are comingDecember 16, 2025 Daniel Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy…
HHealthcare Read More FDA may add strongest safety warning to Covid shotsDecember 12, 2025 A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
HHealthcare Read More Eli Lilly to build $6 billion Alabama manufacturing plantDecember 9, 2025 Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept.…
HHealthcare Read More WHO backs use of GLP-1 therapies for obesity, warns access will remain limitedDecember 2, 2025 A view shows The World Health Organization (WHO) headquarters in Geneva, Switzerland, Jan. 28, 2025. Denis Balibouse |…
HHealthcare Read More Novo Nordisk stumbles against Eli Lilly in GLP-1 drug battle. Which stock is best?November 24, 2025 In the battle between weight-loss drug companies, Eli Lilly has emerged as the clear winner for investors. The…
HHealthcare Read More Novo Nordisk cuts cash prices for Wegovy, OzempicNovember 17, 2025 Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024.…
HHealthcare Read More WeightWatchers to offer Novo Nordisk’s Wegovy pill after 2026 launchNovember 13, 2025 Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
HHealthcare Read More Trump deals with Lilly, Novo Nordisk could broaden obesity drug accessNovember 7, 2025 US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC…
HHealthcare Read More Omada Health to start prescribing GLP-1s, other obesity medicationsNovember 7, 2025 The Omada Health logo is displayed on a smartphone screen. Sopa Images | Lightrocket | Getty Images Virtual…